{"gene":"NCAM1","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":1988,"finding":"NCAM polysialic acid (PSA) content regulates cell-cell adhesion by steric hindrance: high PSA content increases intermembrane repulsion and inhibits membrane apposition, while low PSA content promotes adhesion and triggers contact-dependent intercellular events.","method":"Cell adhesion assays, biochemical analysis of PSA content","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — foundational finding replicated across many subsequent studies with multiple orthogonal methods","pmids":["3281256"],"is_preprint":false},{"year":1996,"finding":"PSA-NCAM is required for activity-induced synaptic plasticity (LTP and LTD) in hippocampal slices; enzymatic removal of PSA with endoneuraminidase-N completely prevented LTP and LTD induction, and recovery of PSA immunoreactivity correlated with full recovery of plasticity. NCAM-deficient mice also showed decaying LTP.","method":"Enzymatic PSA removal (endoneuraminidase-N), hippocampal organotypic slice cultures, electrophysiology in NCAM knockout mice","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct enzymatic intervention plus genetic knockout, replicated with multiple approaches in same study","pmids":["8816705"],"is_preprint":false},{"year":1997,"finding":"NCAM is essential for axonal fasciculation and pathfinding of hippocampal mossy fibers in vivo; NCAM-null mice show strongly disrupted fasciculation, pathfinding, and altered distribution of mossy fiber terminals, with a more severe phenotype in adults than young animals.","method":"NCAM knockout mice (gene targeting), histological and immunofluorescence analysis of hippocampal mossy fiber tract","journal":"Molecular and cellular neurosciences","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockout with defined anatomical phenotype, replicated across developmental stages","pmids":["9073395"],"is_preprint":false},{"year":1999,"finding":"NCAM140 clustering activates a signaling cascade: p125FAK → p59Fyn → Ras → MEK → ERK1/2 (MAPK) activation, leading to CREB phosphorylation at Ser133. This pathway is required for NCAM-stimulated neurite outgrowth in cerebellar neurons.","method":"NCAM clustering assay, phosphorylation assays (Western blot), kinase inhibitors, dominant-negative constructs, neurite outgrowth assay","journal":"Journal of neurobiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple signaling intermediates identified with inhibitor experiments and phosphorylation assays in a single study","pmids":["10084688"],"is_preprint":false},{"year":2000,"finding":"Crystal structure (1.85 Å) of the two N-terminal extracellular Ig domains of NCAM reveals a cross-shaped antiparallel dimer as the structural basis for homophilic trans-cellular recognition and adhesion.","method":"X-ray crystallography","journal":"Nature structural biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structure providing direct structural basis for homophilic binding","pmids":["10802736"],"is_preprint":false},{"year":2002,"finding":"Lipid raft association of NCAM140 is required for activation of the non-receptor tyrosine kinase pathway (FAK and ERK1/2) and neurite outgrowth. Mutation of NCAM140 palmitoylation sites or lipid raft disruption abolishes tyrosine kinase activation and neurite outgrowth. Additionally, FGF receptor co-signaling is also required, as a specific FGFR inhibitor completely blocks NCAM-triggered neurite outgrowth.","method":"Transfection of NCAM-deficient hippocampal neurons, palmitoylation site mutagenesis, lipid raft disruption (methyl-β-cyclodextrin), FGFR-specific inhibitor, kinase phosphorylation assays, neurite outgrowth assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — mutagenesis, pharmacological disruption, and functional readout in same study with multiple orthogonal methods","pmids":["11980923"],"is_preprint":false},{"year":2002,"finding":"NCAM140 reduces cell motility by interfering with fibronectin substratum attachment and through its cytoplasmic domain via interaction with p59Fyn. The extracellular domain of NCAM also acts as a paracrine inhibitor of NCAM-negative cell locomotion via heterophilic interaction with heparan sulfate proteoglycans (through the two N-terminal Ig modules).","method":"NCAM transfection, motility assays, fibronectin adhesion assay, domain deletion constructs, heparin-binding assays","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple domain constructs and functional assays in single study, single lab","pmids":["11839780"],"is_preprint":false},{"year":2003,"finding":"NCAM120, NCAM140, and NCAM180 form detergent-insoluble complexes with βI spectrin in hippocampal neurons. βI spectrin binds directly to the intracellular domain of NCAM180 and to NCAM140. PKCβ2 forms complexes with NCAM140/NCAM180 via spectrin as a bridge. NCAM activation promotes redistribution of the NCAM-spectrin-PKCβ2 complex to lipid rafts, and disruption of spectrin binding (by dominant-negative βI spectrin fragments) impairs neurite outgrowth.","method":"Co-immunoprecipitation, subcellular fractionation (Triton X-100 insoluble complexes/lipid rafts), dominant-negative constructs, methyl-β-cyclodextrin treatment, neurite outgrowth assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, dominant-negative functional assay, lipid raft disruption, multiple orthogonal methods","pmids":["12743109"],"is_preprint":false},{"year":2004,"finding":"NCAM140 directly interacts with the intracellular domain of RPTPα (receptor-like protein tyrosine phosphatase alpha) in a Ca2+-independent manner. This NCAM-RPTPα complex is bridged by spectrin and redistributes to lipid rafts upon NCAM activation. RPTPα is required to link NCAM to p59Fyn kinase activation; in RPTPα-deficient neurons, NCAM-Fyn association and Fyn activation are abolished, and NCAM-dependent neurite outgrowth is blocked.","method":"Co-immunoprecipitation, RPTPα-deficient mouse neurons, dominant-negative RPTPα mutants, kinase activation assays, neurite outgrowth assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct interaction, knockout confirmation, dominant-negative validation, and functional readout in one study","pmids":["15623578"],"is_preprint":false},{"year":2004,"finding":"NCAM polysialylation directly increases intermembrane repulsion (measured by molecular force measurements), sufficient to overwhelm homophilic NCAM adhesion and cadherin-mediated adhesion. The steric repulsion is ionic strength-dependent, and PSA-dependent attenuation of cadherin adhesion increases with PSA-NCAM:cadherin ratio.","method":"Molecular force measurements (surface force apparatus) using membrane-bound NCAM with and without PSA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — quantitative biophysical reconstitution measuring direct repulsive force, rigorous controls for ionic strength and PSA density","pmids":["15504723"],"is_preprint":false},{"year":2006,"finding":"GAP-43 phosphorylation (by PKC and CKII) potentiates NCAM-induced neurite outgrowth. In the presence of GAP-43, NCAM-180/spectrin/GAP-43 functional association is required for neurite outgrowth; in the absence of GAP-43, the NCAM-140/Fyn signaling pathway is predominant. GAP-43 thus acts as a molecular switch between NCAM-180 and NCAM-140 signaling.","method":"Overexpression and phosphorylation mutants in PC12E2 cells and hippocampal neurons, neurite outgrowth assay, co-immunoprecipitation","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple isoform constructs, phosphorylation mutants, and functional assays in single lab","pmids":["17212696"],"is_preprint":false},{"year":2008,"finding":"NCAM clustering induces Ca2+ influx via T- and L-type voltage-dependent Ca2+ channels associated with NCAM, activating CaMKIIα which phosphorylates RPTPα at Ser180 and Ser204, enhancing RPTPα phosphatase activity. Overexpression of RPTPα with mutated Ser180/Ser204 inhibits NCAM-induced neurite outgrowth.","method":"Co-immunoprecipitation, Ca2+ channel blockers, CaMKIIα inhibitors, phosphorylation assays, RPTPα serine mutagenesis, neurite outgrowth assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct binding, mutagenesis, kinase cascade dissection, and functional readout with multiple orthogonal methods","pmids":["18809727"],"is_preprint":false},{"year":2009,"finding":"Neuronal membrane depolarization triggers skipping of NCAM exon 18 independently of the CaMKIV pathway, through a kinetic coupling mechanism: H3K9 hyper-acetylation is induced in an intragenic region surrounding the alternative exon (without promoter acetylation), associated with chromatin relaxation and H3K36 tri-methylation, which accelerates RNA Pol II elongation and promotes exon skipping.","method":"Depolarization of neuronal cells, slow RNAP II mutant, chromatin immunoprecipitation (H3K9ac, H3K36me3), HDAC inhibitor trichostatin A, RT-PCR for alternative splicing","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple chromatin assays, genetic RNAP II mutant, pharmacological validation with reversion experiment","pmids":["19251664"],"is_preprint":false},{"year":2009,"finding":"Ectopic expression of NCAM140 in radial glia and type C cells in vivo induces increased cell proliferation and generation of additional neuronal type A cells in the rostral migratory stream. This neurogenic effect requires only the fibronectin type III repeats and Ig-domain 5 of NCAM and is independent of polysialylation (as transgenic NCAM in these cells is not polysialylated), implicating heterophilic NCAM interactions.","method":"In vivo retroviral/lentiviral overexpression in postnatal mouse brain, domain deletion mutants, PSA immunostaining, cell counting (BrdU/doublecortin)","journal":"The European journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain mapping with deletion mutants in vivo, single lab","pmids":["19788570"],"is_preprint":false},{"year":2013,"finding":"NCAM directly interacts with p21-activated kinase 1 (Pak1) in growth cones (identified by yeast two-hybrid and confirmed in neurons). NCAM activation enhances Pak1 autophosphorylation/activity, promotes Pak1 membrane association, and activates downstream LIMK1 and cofilin phosphorylation, increasing filamentous actin and filopodium mobility. Pak1 is required for NCAM-dependent neurite outgrowth.","method":"Yeast two-hybrid screen, co-immunoprecipitation in growth cones, NCAM-deficient mouse brains, dominant-negative and constitutively active Pak1 constructs, actin polymerization assay, neurite outgrowth assay","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — yeast two-hybrid identified interaction confirmed by co-IP in neurons, knockout validation, gain/loss-of-function of downstream effector, multiple orthogonal methods","pmids":["23303955"],"is_preprint":false},{"year":2017,"finding":"TGFβ1 induces NCAM1 expression in cardiomyocytes via a p38-dependent pathway. NCAM1 upregulation mediates TGFβ1-induced cell-cell adhesion defects at intercalated discs; selective targeting of NCAM1 rescues the cell adhesion defect caused by TGFβ1 treatment.","method":"Cardiac-specific TGFβ1 transgenic mice, electron microscopy, immunostaining, p38 inhibition, siRNA knockdown of NCAM1, rescue assay in cardiomyocytes","journal":"Journal of molecular and cellular cardiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway dissection with p38 inhibitor and NCAM1 knockdown rescue, single lab","pmids":["28870505"],"is_preprint":false},{"year":2017,"finding":"GFRα1 counteracts NCAM function during Purkinje cell migration: GFRα1 directly interacts with NCAM in embryonic Purkinje cells, and genetic reduction of NCAM enhances wild-type Purkinje cell migration and restores migration in Gfra1 mutants. GFRα1 can act both in cis and trans to limit NCAM-mediated restriction of Purkinje cell migration.","method":"Gfra1 and Ncam knockout/heterozygous mice, co-immunoprecipitation of GFRα1 and NCAM, in vitro migration assays with cis/trans GFRα1 constructs","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis (double mutant rescue), direct protein interaction, and in vitro mechanistic validation","pmids":["28076782"],"is_preprint":false},{"year":2018,"finding":"Peripheral nerve injury increases NCAM1 turnover in the anterior cingulate cortex (ACC), and NCAM1 mediates spine reorganization in ACC neurons contributing to behavioral sensitization (neuropathic pain). This mechanism parallels NMDA-receptor- and protein-synthesis-dependent LTP maintenance.","method":"Peripheral nerve injury model, protein turnover assays, spine morphology analysis, behavioral sensitization tests, NCAM1 manipulation in ACC","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with defined spine reorganization and behavioral phenotype, single lab","pmids":["29346771"],"is_preprint":false},{"year":2019,"finding":"NCAM1 promotes leukemogenesis and confers drug resistance in AML by constitutively activating the MAPK signaling pathway. NCAM1 perturbation induces cell death or differentiation and sensitizes leukemic blasts to genotoxic agents in vitro and in vivo. In a murine AML model, Ncam1 deletion prolonged disease latency and reduced leukemia-initiating cells. Pharmacological MEK1/2 inhibition specifically inhibits NCAM1+ AML cell proliferation.","method":"CRISPR/Cas9 knockout and shRNA knockdown, phosphoproteomics, transcriptomics, serial transplantation in murine AML model, MEK1/2 inhibitor treatment, in vitro and in vivo drug sensitivity assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — complementary genetic strategies (CRISPR + shRNA), phosphoproteomics pathway mapping, in vivo serial transplantation, replicated with pharmacological inhibition","pmids":["30814062"],"is_preprint":false},{"year":2020,"finding":"NCAM1 functions as an entry receptor for Zika virus (ZIKV): chemical proteomics with photo-crosslinking identified NCAM1 as a ZIKV-interacting protein in living cells, and overexpression, knockout, and inhibition of NCAM1 in Vero cells and human glioblastoma cells validated its role in ZIKV internalization.","method":"Time-resolved chemical proteomics (photocrosslinking + biotin enrichment + mass spectrometry), NCAM1 overexpression, CRISPR knockout, inhibition in cell lines","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — chemical crosslinking proteomics for receptor identification, validated by three orthogonal genetic approaches (OE, KO, inhibition)","pmids":["32753727"],"is_preprint":false},{"year":2020,"finding":"CD56 (NCAM1) regulates NK cell cytotoxicity through Pyk2: CD56 deletion in NK92 cells impairs immunological synapse formation, lytic granule polarization and exocytosis, and reduces Pyk2 phosphorylation at Tyr402. Reintroduction of CD56 rescues cytotoxicity, granule exocytosis, and Pyk2 phosphorylation.","method":"CRISPR/Cas9 CD56 knockout in NK92 cells, rescue by CD56 reintroduction, lytic granule exocytosis assay, immunological synapse imaging, Pyk2 phosphorylation assay","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean CRISPR KO with full rescue experiment, defined biochemical (Pyk2 phosphorylation) and functional (exocytosis, cytotoxicity) readouts","pmids":["32510326"],"is_preprint":false},{"year":2020,"finding":"NCAM regulates temporal specification of neural progenitor cells (NPCs) during corticogenesis by interacting with profilin2 to enhance actin polymerization. NPC-specific NCAM deletion reduces NPC proliferation, delays cortical neuron production, and advances gliogenesis. Mutations in the profilin2-binding site of NCAM abolish these regulatory effects.","method":"NPC-specific NCAM conditional knockout mice, co-immunoprecipitation of NCAM-profilin2, actin polymerization assay, profilin2-binding site mutagenesis, BrdU/EdU labeling, cortical layer marker immunostaining","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — conditional knockout, direct binding validated by co-IP, site-directed mutagenesis, and in vivo cellular phenotype","pmids":["31816056"],"is_preprint":false},{"year":2022,"finding":"Anti-NCAM1 autoantibodies from schizophrenia patients disrupt NCAM1-NCAM1 homophilic interactions, NCAM1-GDNF interactions, and the NCAM1-Fyn interaction; they inhibit FAK, MEK1, and ERK1 phosphorylation when introduced into mouse cerebrospinal fluid, reduce spine and synapse density in frontal cortex, and induce schizophrenia-related behavior (deficient pre-pulse inhibition and cognitive impairment).","method":"Cell-based assay and ELISA for autoantibody detection; purified patient antibody injection into mouse CSF; spine/synapse counting by immunofluorescence; behavioral tests (PPI, cognitive tasks); phosphorylation assays","journal":"Cell reports. Medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — patient-derived antibody with in vivo functional consequence and downstream signaling measured, but single lab and partially dependent on patient material","pmids":["35492247"],"is_preprint":false},{"year":2023,"finding":"KLK8 (kallikrein-related peptidase 8) proteolytically cleaves the extracellular domain of NCAM1. KLK8-mediated NCAM1 cleavage contributes to hippocampal neuronal apoptosis in CUMS-induced depression. Overexpression of NCAM1 or NCAM1 mimetic peptide rescues neurons from KLK8-induced apoptosis.","method":"Co-immunoprecipitation, in vitro cleavage assay, adenovirus-mediated KLK8 overexpression in hippocampal neurons, KLK8 transgenic and knockout mice, NCAM1 overexpression rescue, CUMS mouse/rat models, immunofluorescence","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct cleavage assay and rescue experiments, single lab with multiple genetic and cellular approaches","pmids":["37076499"],"is_preprint":false},{"year":1996,"finding":"Polysialylation of NCAM is catalyzed by a single enzyme (PST-1/ST8SIA4) acting on terminal sialylated N-glycans on NCAM; reconstitution in vitro using incompletely glycosylated NCAM variants and soluble recombinant PST-1 demonstrated that a single enzyme is sufficient and that terminal sialylation of the N-glycan core (via either α2,3 or α2,6 linkage to galactose) generates the PSA acceptor site.","method":"In vitro reconstitution with recombinant PST-1, incompletely glycosylated NCAM variants, glycosyltransferase assay","journal":"Current biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro enzymatic reconstitution with defined substrates demonstrating single-enzyme catalysis","pmids":["8805371"],"is_preprint":false},{"year":2001,"finding":"LEF-1 and Alx4 can bind simultaneously to adjacent sites on the NCAM promoter (through Alx4's proline-rich N-terminal domain interacting with LEF-1's HMG-box), and this binding alters NCAM promoter activity. Alx4 expression in primary mammary stromal cells decreases endogenous NCAM protein levels.","method":"Protein interaction assays (co-immunoprecipitation/GST pulldown), EMSA on NCAM promoter, promoter reporter assay, endogenous NCAM protein measurement in Alx4-transfected stromal cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding mapped to specific domains, promoter binding and activity assay, endogenous protein regulation, single lab","pmids":["11696550"],"is_preprint":false},{"year":2007,"finding":"ST8SiaIV (PST) is the major regulator of NCAM polysialylation in vivo based on differential mRNA expression correlating with PSA levels; ST8SiaII and ST8SiaIV both polysialylate N-glycosylation sites 5 and 6 of NCAM but produce polySia chains of different lengths, with synergistic action required for synthesis of long polySia chains at site 5.","method":"ST8SiaII and ST8SiaIV knockout mice; isolation and tryptic digestion of polySia-NCAM from mouse brains; glycan structural analysis of polysialylated glycopeptides","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vivo structural analysis with single and double enzyme knockout mice plus glycan fine-structure characterization","pmids":["17986444"],"is_preprint":false}],"current_model":"NCAM1 (CD56) is a multifunctional Ig-superfamily cell adhesion molecule that mediates homophilic adhesion via an antiparallel cis-dimer/trans-zipper mechanism (crystal structure defined), and whose adhesive properties are negatively regulated by polysialic acid (PSA) modification—catalyzed by ST8SIA2/ST8SIA4—through steric intermembrane repulsion; upon homophilic or heterophilic engagement, the NCAM140 isoform signals via lipid-raft-dependent activation of a FAK/Fyn/Ras/MAPK/CREB cascade—requiring RPTPα as a phosphatase bridge to Fyn, spectrin as a scaffold for PKCβ2 and GAP-43 recruitment, CaMKIIα-mediated RPTPα activation via NCAM-associated Ca2+ channels, and Pak1-mediated actin polymerization via LIMK1/cofilin—to drive neurite outgrowth, while in neural progenitors NCAM regulates actin polymerization via profilin2 to control cortical neuron vs. glia fate; in NK cells NCAM1/CD56 promotes cytotoxic lytic granule exocytosis through Pyk2 phosphorylation; in AML cells NCAM1 maintains leukemic stem cells via constitutive MAPK activation; and the extracellular domain can be proteolytically cleaved by KLK8 or act as a Zika virus entry receptor."},"narrative":{"mechanistic_narrative":"NCAM1 (CD56) is an immunoglobulin-superfamily cell adhesion molecule that mediates homophilic trans-cellular recognition through an antiparallel, cross-shaped dimer formed by its N-terminal Ig domains [PMID:10802736], and that organizes axonal fasciculation, synaptic plasticity, and neuronal migration in the nervous system [PMID:8816705, PMID:9073395]. Its adhesive activity is tuned post-translationally by polysialic acid (PSA): polysialylation, catalyzed by the ST8SIA enzymes (PST-1/ST8SIA4 and ST8SIA2) on terminal sialylated N-glycans [PMID:8805371, PMID:17986444], generates steric intermembrane repulsion that overrides homophilic NCAM and cadherin adhesion in a force- and ionic-strength-dependent manner [PMID:15504723, PMID:3281256], and PSA is required for hippocampal LTP and LTD [PMID:8816705]. Upon clustering, the NCAM140 isoform signals from lipid rafts through a non-receptor tyrosine kinase cascade—FAK→Fyn→Ras→MEK→ERK1/2→CREB—to drive neurite outgrowth [PMID:10084688, PMID:11980923], a cascade assembled by a βI-spectrin scaffold that bridges PKCβ2 and GAP-43 [PMID:12743109, PMID:17212696] and by RPTPα, which links NCAM to Fyn and is itself activated by CaMKIIα-mediated phosphorylation downstream of NCAM-associated Ca2+ channels [PMID:15623578, PMID:18809727]. NCAM also remodels the actin cytoskeleton, activating Pak1→LIMK1→cofilin to promote filopodial actin polymerization [PMID:23303955] and engaging profilin2 to control neural progenitor proliferation and the neuron-versus-glia fate decision during corticogenesis [PMID:31816056]. Beyond the nervous system, NCAM1 sustains acute myeloid leukemia stem cells through constitutive MAPK activation, rendering NCAM1+ blasts sensitive to MEK1/2 inhibition [PMID:30814062], promotes NK-cell cytotoxicity by supporting immunological synapse formation and lytic granule exocytosis via Pyk2 phosphorylation [PMID:32510326], and serves as a Zika virus entry receptor [PMID:32753727]. Its ectodomain is proteolytically cleaved by KLK8, linking NCAM1 loss to hippocampal neuronal apoptosis [PMID:37076499], and anti-NCAM1 autoantibodies that disrupt its homophilic and Fyn interactions produce schizophrenia-related deficits [PMID:35492247].","teleology":[{"year":1988,"claim":"Established that NCAM adhesive function is not constitutive but is set by a post-translational modification, defining PSA as a regulatory switch on cell-cell apposition.","evidence":"Cell adhesion assays correlating PSA content with intermembrane repulsion","pmids":["3281256"],"confidence":"High","gaps":["Did not quantify the physical repulsive force","Enzymes generating PSA not yet identified"]},{"year":1996,"claim":"Resolved how PSA-NCAM is biosynthesized by showing a single recombinant enzyme suffices to polysialylate terminally sialylated N-glycans, defining the acceptor requirement.","evidence":"In vitro reconstitution with recombinant PST-1/ST8SIA4 and incompletely glycosylated NCAM variants","pmids":["8805371"],"confidence":"High","gaps":["In vivo contribution of multiple sialyltransferases not addressed","Chain-length determinants unresolved"]},{"year":1996,"claim":"Connected PSA-NCAM to functional plasticity, showing PSA is required for activity-dependent LTP/LTD and that NCAM loss degrades plasticity.","evidence":"Enzymatic PSA removal and electrophysiology in NCAM knockout hippocampal slices","pmids":["8816705"],"confidence":"High","gaps":["Downstream signaling linking PSA to plasticity not defined","Synaptic versus extrasynaptic site of action unresolved"]},{"year":1997,"claim":"Demonstrated an in vivo developmental requirement for NCAM in axonal fasciculation and pathfinding, anchoring its adhesive role in circuit assembly.","evidence":"Histological analysis of mossy fiber tracts in NCAM knockout mice","pmids":["9073395"],"confidence":"High","gaps":["Did not separate homophilic from heterophilic contributions","Molecular signaling mechanism not addressed"]},{"year":2000,"claim":"Provided the structural basis for homophilic recognition, revealing an antiparallel cross-shaped Ig-domain dimer as the trans-adhesion unit.","evidence":"1.85 Å X-ray crystallography of the two N-terminal Ig domains","pmids":["10802736"],"confidence":"High","gaps":["Full-length ectodomain trans-zipper geometry not captured","Effect of PSA on the binding interface not modeled"]},{"year":1999,"claim":"Defined the intracellular signaling consequence of NCAM engagement as a FAK→Fyn→Ras→MAPK→CREB cascade required for neurite outgrowth, converting adhesion into a transcriptional response.","evidence":"NCAM140 clustering, kinase inhibitors, dominant-negatives, and neurite outgrowth assays in cerebellar neurons","pmids":["10084688"],"confidence":"High","gaps":["How clustering reaches FAK/Fyn not yet mechanistically defined","Membrane platform for signaling unidentified"]},{"year":2002,"claim":"Localized NCAM140 signaling to lipid rafts via palmitoylation and revealed obligatory FGFR co-signaling, explaining where and with which partner the kinase cascade is triggered.","evidence":"Palmitoylation mutagenesis, raft disruption, FGFR inhibition, and neurite outgrowth in NCAM-deficient neurons","pmids":["11980923"],"confidence":"High","gaps":["Molecular link between rafts and FAK/Fyn activation not yet specified","Stoichiometry of NCAM-FGFR engagement unresolved"]},{"year":2002,"claim":"Showed NCAM140 also restrains cell motility through Fyn and through heterophilic engagement of heparan sulfate proteoglycans, broadening its role beyond promotion of outgrowth.","evidence":"Motility/adhesion assays and domain-deletion constructs in transfected cells","pmids":["11839780"],"confidence":"Medium","gaps":["Single-lab functional assays","In vivo relevance of the paracrine motility inhibition not tested"]},{"year":2003,"claim":"Identified βI spectrin as the scaffold that physically bridges NCAM to PKCβ2 and recruits the complex to rafts, providing the structural organizer of the signaling assembly.","evidence":"Reciprocal co-IP, raft fractionation, dominant-negative spectrin, and neurite outgrowth assays","pmids":["12743109"],"confidence":"High","gaps":["How spectrin coordinates with the Fyn arm not fully resolved","Isoform-specific scaffolding differences only partly defined"]},{"year":2004,"claim":"Resolved how NCAM activates Fyn by identifying RPTPα as the phosphatase bridge required for Fyn association and activation, filling the gap between clustering and kinase activity.","evidence":"Co-IP, RPTPα-deficient neurons, dominant-negative RPTPα, and neurite outgrowth assays","pmids":["15623578"],"confidence":"High","gaps":["Trigger for RPTPα phosphatase activation not yet identified","Cis versus trans engagement requirement unresolved"]},{"year":2004,"claim":"Quantitatively demonstrated that polysialylation generates a direct repulsive force sufficient to override both NCAM and cadherin adhesion, providing the biophysical mechanism for PSA-dependent de-adhesion.","evidence":"Surface force apparatus measurements on membrane-bound NCAM ± PSA","pmids":["15504723"],"confidence":"High","gaps":["In vivo membrane-context validation limited","Effect on heterophilic ligands beyond cadherin not measured"]},{"year":2006,"claim":"Defined GAP-43 as a molecular switch directing signaling between the NCAM180/spectrin and NCAM140/Fyn pathways, explaining isoform-specific routing of the outgrowth signal.","evidence":"Isoform and phosphorylation-mutant overexpression, co-IP, and neurite outgrowth in PC12E2 cells and neurons","pmids":["17212696"],"confidence":"Medium","gaps":["Single-lab data","Physiological context selecting one pathway over the other not defined"]},{"year":2008,"claim":"Identified the activation trigger for RPTPα as a Ca2+/CaMKIIα circuit, showing NCAM-associated Ca2+ channels phosphorylate RPTPα to enhance its phosphatase activity.","evidence":"Ca2+ channel blockers, CaMKIIα inhibitors, RPTPα Ser180/Ser204 mutagenesis, and neurite outgrowth assays","pmids":["18809727"],"confidence":"High","gaps":["Identity and gating of the NCAM-associated channels not fully defined","Spatial coupling of channels to the signaling complex unresolved"]},{"year":2009,"claim":"Connected neuronal depolarization to NCAM isoform choice via a chromatin/elongation kinetic-coupling mechanism, revealing activity-dependent regulation of NCAM exon 18 splicing.","evidence":"Depolarization, slow RNAP II mutant, ChIP for H3K9ac/H3K36me3, and HDAC inhibition with RT-PCR","pmids":["19251664"],"confidence":"High","gaps":["Functional consequence of the spliced isoform not tested here","Upstream signal linking depolarization to chromatin marks not defined"]},{"year":2009,"claim":"Showed NCAM140 promotes neurogenic proliferation in vivo through heterophilic, PSA-independent interactions, mapping the activity to the FnIII repeats and Ig domain 5.","evidence":"In vivo viral overexpression with domain-deletion mutants and BrdU/doublecortin counting","pmids":["19788570"],"confidence":"Medium","gaps":["Heterophilic partner not identified","Single-lab in vivo evidence"]},{"year":2013,"claim":"Linked NCAM signaling to direct actin remodeling by identifying Pak1 as a partner driving LIMK1/cofilin-dependent actin polymerization in growth cones.","evidence":"Yeast two-hybrid, co-IP in growth cones, NCAM-deficient brains, Pak1 gain/loss constructs, and actin/neurite assays","pmids":["23303955"],"confidence":"High","gaps":["Coordination between Pak1 and the FAK/Fyn cascade unresolved","Direct binding interface not mapped"]},{"year":2020,"claim":"Extended NCAM cytoskeletal control to cell-fate decisions, showing NCAM-profilin2 interaction tunes actin polymerization to set the timing of cortical neurogenesis versus gliogenesis.","evidence":"NPC-specific conditional knockout, NCAM-profilin2 co-IP, binding-site mutagenesis, and cortical layer/lineage analysis","pmids":["31816056"],"confidence":"High","gaps":["Signal upstream of profilin2 engagement not defined","Relationship to PSA regulation in NPCs unclear"]},{"year":2017,"claim":"Demonstrated NCAM acts in functional opposition to GFRα1 during Purkinje cell migration, establishing genetic epistasis between an adhesion molecule and a GDNF co-receptor.","evidence":"Gfra1/Ncam mutant epistasis, GFRα1-NCAM co-IP, and cis/trans migration assays","pmids":["28076782"],"confidence":"High","gaps":["Downstream effectors of the GFRα1-NCAM interaction not defined","Whether intracellular signaling is engaged unresolved"]},{"year":2017,"claim":"Implicated NCAM1 in cardiac pathology, showing TGFβ1 induces NCAM1 via p38 to cause intercalated-disc adhesion defects.","evidence":"Cardiac TGFβ1 transgenic mice, p38 inhibition, NCAM1 siRNA knockdown, and rescue in cardiomyocytes","pmids":["28870505"],"confidence":"Medium","gaps":["Single-lab study","Mechanism by which NCAM1 disrupts disc adhesion not defined"]},{"year":2018,"claim":"Extended NCAM1's plasticity role to disease by showing injury-induced NCAM1 turnover mediates cortical spine reorganization and behavioral sensitization in neuropathic pain.","evidence":"Nerve injury model, protein turnover and spine morphology analysis, and ACC NCAM1 manipulation with behavioral tests","pmids":["29346771"],"confidence":"Medium","gaps":["Molecular signaling driving spine changes not defined","Single-lab study"]},{"year":2019,"claim":"Established a non-neural pathogenic role, showing NCAM1 maintains AML leukemic stem cells through constitutive MAPK activation and confers a MEK-inhibitor vulnerability.","evidence":"CRISPR/shRNA depletion, phosphoproteomics, serial transplantation in murine AML, and MEK1/2 inhibition","pmids":["30814062"],"confidence":"High","gaps":["How NCAM1 constitutively engages MAPK in leukemia not defined","Ligand/clustering requirement in AML unresolved"]},{"year":2020,"claim":"Defined a mechanism for NCAM1 in immune cytotoxicity, showing CD56 supports immunological synapse formation and lytic granule exocytosis through Pyk2 phosphorylation.","evidence":"CRISPR knockout with rescue in NK92 cells, synapse imaging, exocytosis assays, and Pyk2 phosphorylation","pmids":["32510326"],"confidence":"High","gaps":["Upstream link from CD56 engagement to Pyk2 not defined","Homophilic versus heterophilic trigger in NK cells unresolved"]},{"year":2020,"claim":"Identified NCAM1 as a Zika virus entry receptor, assigning it a role in viral internalization in neural and other cell types.","evidence":"Photo-crosslinking chemical proteomics with NCAM1 overexpression, knockout, and inhibition in cell lines","pmids":["32753727"],"confidence":"High","gaps":["Viral domain engaging NCAM1 not mapped","Internalization machinery downstream of NCAM1 binding unresolved"]},{"year":2022,"claim":"Connected NCAM1 to schizophrenia, showing patient autoantibodies disrupt homophilic, GDNF, and Fyn interactions, suppress FAK/MEK/ERK signaling, and reduce synapse density to produce disease-related behavior.","evidence":"Patient antibody detection and CSF injection in mice with phosphorylation, spine/synapse, and behavioral readouts","pmids":["35492247"],"confidence":"Medium","gaps":["Single-lab study partly dependent on patient material","Causal role of autoantibodies in patients not established"]},{"year":2023,"claim":"Identified KLK8 as a protease that cleaves the NCAM1 ectodomain and linked this cleavage to hippocampal neuronal apoptosis in a depression model.","evidence":"In vitro cleavage assay, KLK8 overexpression, transgenic/knockout mice, and NCAM1 rescue in CUMS models","pmids":["37076499"],"confidence":"Medium","gaps":["Cleavage site and fate of cleaved fragments not defined","Single-lab study"]},{"year":2007,"claim":"Resolved the in vivo division of labor between polysialyltransferases, showing ST8SiaIV is the major regulator and that ST8SiaII/IV act synergistically to build long polySia chains at specific N-glycan sites.","evidence":"Single and double sialyltransferase knockout mice with glycan fine-structure analysis of brain polySia-NCAM","pmids":["17986444"],"confidence":"High","gaps":["Regulation of enzyme expression/activity not addressed","Functional consequence of differential chain length unresolved"]},{"year":2001,"claim":"Identified transcriptional control of NCAM expression through cooperative LEF-1/Alx4 binding at the NCAM promoter, with Alx4 repressing endogenous NCAM in stromal cells.","evidence":"Co-IP/GST pulldown, EMSA, promoter reporter assays, and endogenous protein measurement","pmids":["11696550"],"confidence":"Medium","gaps":["Tissue contexts using this regulation not broadly defined","Single-lab study"]},{"year":null,"claim":"How the diverse NCAM-engaging signals (homophilic, heterophilic, viral, autoantibody, constitutive in leukemia) are differentially routed into the shared FAK/Fyn/RPTPα/MAPK and actin machinery to produce context-specific outcomes remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["Mechanism of constitutive MAPK engagement in AML undefined","Heterophilic partners for neurogenic and migration roles not all identified","How PSA status integrates with intracellular signaling not mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[0,4,9]},{"term_id":"GO:0001618","term_label":"virus receptor activity","supporting_discovery_ids":[19]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[14,21]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[3,5,8]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[7,8]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[4,5,7]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[14,21]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,5,8,18]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,13,21]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[1,14]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[20]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[18,19,22,23]},{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[0,4]}],"complexes":[],"partners":["FYN","PTPRA","SPTB","PAK1","PFN2","GFRA1","KLK8","GAP43"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P13591","full_name":"Neural cell adhesion molecule 1","aliases":[],"length_aa":858,"mass_kda":94.6,"function":"This protein is a cell adhesion molecule involved in neuron-neuron adhesion, neurite fasciculation, outgrowth of neurites, etc (Microbial infection) Acts as a receptor for rabies virus (Microbial infection) Acts as a receptor for Zika virus","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P13591/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NCAM1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":77,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NCAM1","total_profiled":1310},"omim":[{"mim_id":"617150","title":"ZDHHC PALMITOYLTRANSFERASE 3; ZDHHC3","url":"https://www.omim.org/entry/617150"},{"mim_id":"615669","title":"EMBIGIN; EMB","url":"https://www.omim.org/entry/615669"},{"mim_id":"614172","title":"IMMUNODEFICIENCY 21; IMD21","url":"https://www.omim.org/entry/614172"},{"mim_id":"613961","title":"TASTE RECEPTOR, TYPE 2, MEMBER 19; TAS2R19","url":"https://www.omim.org/entry/613961"},{"mim_id":"610648","title":"CUT-LIKE HOMEOBOX 2; CUX2","url":"https://www.omim.org/entry/610648"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Plasma membrane","reliability":"Enhanced"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":187.4},{"tissue":"heart muscle","ntpm":136.4}],"url":"https://www.proteinatlas.org/search/NCAM1"},"hgnc":{"alias_symbol":["NCAM","CD56"],"prev_symbol":[]},"alphafold":{"accession":"P13591","domains":[{"cath_id":"2.60.40.10","chopping":"20-114","consensus_level":"high","plddt":86.5562,"start":20,"end":114},{"cath_id":"2.60.40.10","chopping":"118-208","consensus_level":"medium","plddt":89.6596,"start":118,"end":208},{"cath_id":"2.60.40.10","chopping":"217-304","consensus_level":"medium","plddt":92.3322,"start":217,"end":304},{"cath_id":"2.60.40.10","chopping":"314-350_360-413","consensus_level":"medium","plddt":86.6123,"start":314,"end":413},{"cath_id":"2.60.40.10","chopping":"420-505","consensus_level":"medium","plddt":93.4486,"start":420,"end":505},{"cath_id":"2.60.40.10","chopping":"513-604","consensus_level":"high","plddt":93.9135,"start":513,"end":604},{"cath_id":"2.60.40.10","chopping":"615-700","consensus_level":"high","plddt":89.6224,"start":615,"end":700}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P13591","model_url":"https://alphafold.ebi.ac.uk/files/AF-P13591-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P13591-F1-predicted_aligned_error_v6.png","plddt_mean":79.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NCAM1","jax_strain_url":"https://www.jax.org/strain/search?query=NCAM1"},"sequence":{"accession":"P13591","fasta_url":"https://rest.uniprot.org/uniprotkb/P13591.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P13591/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P13591"}},"corpus_meta":[{"pmid":"3281256","id":"PMC_3281256","title":"The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions.","date":"1988","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/3281256","citation_count":758,"is_preprint":false},{"pmid":"8816705","id":"PMC_8816705","title":"PSA-NCAM is required for activity-induced synaptic plasticity.","date":"1996","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/8816705","citation_count":515,"is_preprint":false},{"pmid":"2471777","id":"PMC_2471777","title":"Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule.","date":"1989","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2471777","citation_count":468,"is_preprint":false},{"pmid":"17029752","id":"PMC_17029752","title":"PSA-NCAM in mammalian structural plasticity and neurogenesis.","date":"2006","source":"Progress in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/17029752","citation_count":355,"is_preprint":false},{"pmid":"11861268","id":"PMC_11861268","title":"Clinical and biologic features of CD4(+)CD56(+) malignancies.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11861268","citation_count":318,"is_preprint":false},{"pmid":"9073395","id":"PMC_9073395","title":"NCAM is essential for axonal growth and fasciculation in the hippocampus.","date":"1997","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/9073395","citation_count":245,"is_preprint":false},{"pmid":"11980923","id":"PMC_11980923","title":"Cosignaling of NCAM via lipid rafts and the FGF receptor is required for neuritogenesis.","date":"2002","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11980923","citation_count":228,"is_preprint":false},{"pmid":"19251664","id":"PMC_19251664","title":"Neuronal cell depolarization induces intragenic chromatin modifications affecting NCAM alternative splicing.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19251664","citation_count":224,"is_preprint":false},{"pmid":"10084688","id":"PMC_10084688","title":"NCAM stimulates the Ras-MAPK pathway and CREB phosphorylation in neuronal cells.","date":"1999","source":"Journal of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/10084688","citation_count":190,"is_preprint":false},{"pmid":"15504723","id":"PMC_15504723","title":"Direct evidence that neural cell adhesion molecule (NCAM) polysialylation increases intermembrane repulsion and abrogates adhesion.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15504723","citation_count":182,"is_preprint":false},{"pmid":"15662836","id":"PMC_15662836","title":"Zippers make signals: NCAM-mediated molecular interactions and signal transduction.","date":"2004","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/15662836","citation_count":164,"is_preprint":false},{"pmid":"9951628","id":"PMC_9951628","title":"The neural cell adhesion molecule (NCAM) in development and plasticity of the nervous system.","date":"1998","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/9951628","citation_count":162,"is_preprint":false},{"pmid":"17085484","id":"PMC_17085484","title":"Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations.","date":"2006","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17085484","citation_count":157,"is_preprint":false},{"pmid":"9777989","id":"PMC_9777989","title":"Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors.","date":"1998","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/9777989","citation_count":145,"is_preprint":false},{"pmid":"2179732","id":"PMC_2179732","title":"Enhanced myogenesis in NCAM-transfected mouse myoblasts.","date":"1990","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/2179732","citation_count":140,"is_preprint":false},{"pmid":"13130309","id":"PMC_13130309","title":"What is CD4+CD56+ malignancy and how should it be treated?","date":"2003","source":"Bone marrow transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/13130309","citation_count":138,"is_preprint":false},{"pmid":"7526680","id":"PMC_7526680","title":"High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma.","date":"1994","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/7526680","citation_count":137,"is_preprint":false},{"pmid":"16045455","id":"PMC_16045455","title":"Structural biology of NCAM homophilic binding and activation of FGFR.","date":"2005","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16045455","citation_count":136,"is_preprint":false},{"pmid":"17975827","id":"PMC_17975827","title":"NCAM-induced intracellular signaling revisited.","date":"2008","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/17975827","citation_count":127,"is_preprint":false},{"pmid":"17439829","id":"PMC_17439829","title":"CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.","date":"2007","source":"American journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17439829","citation_count":116,"is_preprint":false},{"pmid":"17986140","id":"PMC_17986140","title":"Dissecting polysialic acid and NCAM functions in brain development.","date":"2007","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17986140","citation_count":115,"is_preprint":false},{"pmid":"11831554","id":"PMC_11831554","title":"Revisiting the function of PSA-NCAM in the nervous system.","date":"2001","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/11831554","citation_count":115,"is_preprint":false},{"pmid":"17495133","id":"PMC_17495133","title":"The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17495133","citation_count":113,"is_preprint":false},{"pmid":"12743109","id":"PMC_12743109","title":"Neural cell adhesion molecule (NCAM) association with PKCbeta2 via betaI spectrin is implicated in NCAM-mediated neurite outgrowth.","date":"2003","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12743109","citation_count":112,"is_preprint":false},{"pmid":"1623208","id":"PMC_1623208","title":"NCAM: structural diversity, function and regulation of expression.","date":"1992","source":"Seminars in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/1623208","citation_count":111,"is_preprint":false},{"pmid":"10715576","id":"PMC_10715576","title":"PSA-NCAM: an important regulator of hippocampal plasticity.","date":"2000","source":"International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10715576","citation_count":104,"is_preprint":false},{"pmid":"17413444","id":"PMC_17413444","title":"NCAM1 association study of bipolar disorder and schizophrenia: polymorphisms and alternatively spliced isoforms lead to similarities and differences.","date":"2007","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17413444","citation_count":103,"is_preprint":false},{"pmid":"10802736","id":"PMC_10802736","title":"Structural basis of cell-cell adhesion by NCAM.","date":"2000","source":"Nature structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/10802736","citation_count":102,"is_preprint":false},{"pmid":"1721526","id":"PMC_1721526","title":"Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells.","date":"1991","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/1721526","citation_count":99,"is_preprint":false},{"pmid":"15623578","id":"PMC_15623578","title":"RPTPalpha is essential for NCAM-mediated p59fyn activation and neurite elongation.","date":"2004","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15623578","citation_count":96,"is_preprint":false},{"pmid":"23354723","id":"PMC_23354723","title":"Polysialic acid: versatile modification of NCAM, SynCAM 1 and neuropilin-2.","date":"2013","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/23354723","citation_count":90,"is_preprint":false},{"pmid":"11839780","id":"PMC_11839780","title":"NCAM regulates cell motility.","date":"2002","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/11839780","citation_count":87,"is_preprint":false},{"pmid":"11841427","id":"PMC_11841427","title":"Differential expression of CD56 and CD44 in the evolution of extramedullary myeloma.","date":"2002","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/11841427","citation_count":85,"is_preprint":false},{"pmid":"18308302","id":"PMC_18308302","title":"Neural cell adhesion molecule (NCAM) marks adult myogenic cells committed to differentiation.","date":"2008","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/18308302","citation_count":83,"is_preprint":false},{"pmid":"18828801","id":"PMC_18828801","title":"Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence.","date":"2008","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/18828801","citation_count":82,"is_preprint":false},{"pmid":"30814062","id":"PMC_30814062","title":"NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML.","date":"2019","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/30814062","citation_count":80,"is_preprint":false},{"pmid":"15353284","id":"PMC_15353284","title":"Molecular mechanisms of NCAM function.","date":"2004","source":"Frontiers in bioscience : a journal and virtual library","url":"https://pubmed.ncbi.nlm.nih.gov/15353284","citation_count":74,"is_preprint":false},{"pmid":"17161382","id":"PMC_17161382","title":"NCAM1 and neurocognition in schizophrenia.","date":"2006","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17161382","citation_count":71,"is_preprint":false},{"pmid":"8805371","id":"PMC_8805371","title":"Polysialylation of NCAM by a single enzyme.","date":"1996","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/8805371","citation_count":66,"is_preprint":false},{"pmid":"17212696","id":"PMC_17212696","title":"GAP-43 regulates NCAM-180-mediated neurite outgrowth.","date":"2006","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17212696","citation_count":61,"is_preprint":false},{"pmid":"23303482","id":"PMC_23303482","title":"ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure.","date":"2013","source":"JAMA psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/23303482","citation_count":58,"is_preprint":false},{"pmid":"8501910","id":"PMC_8501910","title":"Neural cell adhesion molecule (NCAM) and perineural invasion in bile duct cancer.","date":"1993","source":"Journal of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/8501910","citation_count":57,"is_preprint":false},{"pmid":"12183105","id":"PMC_12183105","title":"Cadherins and NCAM as potential targets in metal toxicity.","date":"2002","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12183105","citation_count":55,"is_preprint":false},{"pmid":"12937148","id":"PMC_12937148","title":"NCAM(CD56) and RUNX1(AML1) are up-regulated in human ischemic cardiomyopathy and a rat model of chronic cardiac ischemia.","date":"2003","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/12937148","citation_count":55,"is_preprint":false},{"pmid":"14742908","id":"PMC_14742908","title":"NCAM mimetic peptides: Pharmacological and therapeutic potential.","date":"2004","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/14742908","citation_count":54,"is_preprint":false},{"pmid":"1706237","id":"PMC_1706237","title":"Expression of the neural cell adhesion molecule (CD56) by human myeloma cells.","date":"1991","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1706237","citation_count":54,"is_preprint":false},{"pmid":"7643959","id":"PMC_7643959","title":"Neural cell adhesion molecule (NCAM) as a quantitative marker in synaptic remodeling.","date":"1995","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/7643959","citation_count":54,"is_preprint":false},{"pmid":"17986444","id":"PMC_17986444","title":"Enzyme-dependent variations in the polysialylation of the neural cell adhesion molecule (NCAM) in vivo.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17986444","citation_count":54,"is_preprint":false},{"pmid":"37563308","id":"PMC_37563308","title":"Identification of human exTreg cells as CD16+CD56+ cytotoxic CD4+ T cells.","date":"2023","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37563308","citation_count":53,"is_preprint":false},{"pmid":"26478212","id":"PMC_26478212","title":"L1-CAM and N-CAM: From Adhesion Proteins to Pharmacological Targets.","date":"2015","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26478212","citation_count":53,"is_preprint":false},{"pmid":"32510326","id":"PMC_32510326","title":"CD56 regulates human NK cell cytotoxicity through Pyk2.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32510326","citation_count":51,"is_preprint":false},{"pmid":"32753727","id":"PMC_32753727","title":"Chemical proteomics tracks virus entry and uncovers NCAM1 as Zika virus receptor.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32753727","citation_count":49,"is_preprint":false},{"pmid":"1985868","id":"PMC_1985868","title":"Characterization of NCAM expression and function in BT4C and BT4Cn glioma cells.","date":"1991","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/1985868","citation_count":48,"is_preprint":false},{"pmid":"15914364","id":"PMC_15914364","title":"CD56/NCAM-positive Langerhans cell sarcoma: a clinicopathologic study of 4 cases.","date":"2005","source":"International journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/15914364","citation_count":48,"is_preprint":false},{"pmid":"8245222","id":"PMC_8245222","title":"NCAM expression by subsets of taste cells is dependent upon innervation.","date":"1993","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/8245222","citation_count":46,"is_preprint":false},{"pmid":"11696550","id":"PMC_11696550","title":"Alx4 binding to LEF-1 regulates N-CAM promoter activity.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11696550","citation_count":45,"is_preprint":false},{"pmid":"29346771","id":"PMC_29346771","title":"Rapid Turnover of Cortical NCAM1 Regulates Synaptic Reorganization after Peripheral Nerve Injury.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29346771","citation_count":44,"is_preprint":false},{"pmid":"15466379","id":"PMC_15466379","title":"Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis.","date":"2004","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/15466379","citation_count":43,"is_preprint":false},{"pmid":"7512851","id":"PMC_7512851","title":"NCAM (CD56)-positive malignant lymphoma.","date":"1993","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/7512851","citation_count":40,"is_preprint":false},{"pmid":"8194895","id":"PMC_8194895","title":"NCAM and lung cancer.","date":"1994","source":"International journal of cancer. Supplement = Journal international du cancer. Supplement","url":"https://pubmed.ncbi.nlm.nih.gov/8194895","citation_count":40,"is_preprint":false},{"pmid":"18425046","id":"PMC_18425046","title":"Expression of CD56 and WT1 in ovarian stroma and ovarian stromal tumors.","date":"2008","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18425046","citation_count":39,"is_preprint":false},{"pmid":"18213713","id":"PMC_18213713","title":"Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation status.","date":"2008","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18213713","citation_count":38,"is_preprint":false},{"pmid":"18809727","id":"PMC_18809727","title":"NCAM induces CaMKIIalpha-mediated RPTPalpha phosphorylation to enhance its catalytic activity and neurite outgrowth.","date":"2008","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18809727","citation_count":38,"is_preprint":false},{"pmid":"11976973","id":"PMC_11976973","title":"The role of NCAM in remyelination.","date":"2002","source":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/11976973","citation_count":37,"is_preprint":false},{"pmid":"14871854","id":"PMC_14871854","title":"Ex vivo expansion of CD8+CD56+ and CD8+CD56- natural killer T cells specific for MUC1 mucin.","date":"2004","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/14871854","citation_count":37,"is_preprint":false},{"pmid":"15270860","id":"PMC_15270860","title":"CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection.","date":"2004","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15270860","citation_count":36,"is_preprint":false},{"pmid":"10772795","id":"PMC_10772795","title":"Neural cell adhesion molecule (NCAM) and myoblast fusion.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10772795","citation_count":36,"is_preprint":false},{"pmid":"15965442","id":"PMC_15965442","title":"Mycosis fungoides with a CD56+ immunophenotype.","date":"2005","source":"Journal of the American Academy of Dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/15965442","citation_count":36,"is_preprint":false},{"pmid":"11089916","id":"PMC_11089916","title":"Control of NCAM polysialylation by the differential expression of polysialyltransferases ST8SiaII and ST8SiaIV.","date":"2000","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11089916","citation_count":35,"is_preprint":false},{"pmid":"23303955","id":"PMC_23303955","title":"The neural cell adhesion molecule (NCAM) associates with and signals through p21-activated kinase 1 (Pak1).","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23303955","citation_count":35,"is_preprint":false},{"pmid":"35148379","id":"PMC_35148379","title":"NCAM1 and GDF15 are biomarkers of Charcot-Marie-Tooth disease in patients and mice.","date":"2022","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35148379","citation_count":33,"is_preprint":false},{"pmid":"32269209","id":"PMC_32269209","title":"Upregulation of Neural Cell Adhesion Molecule 1 (NCAM1) by hsa-miR-141-3p Suppresses Ameloblastoma Cell Migration.","date":"2020","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/32269209","citation_count":33,"is_preprint":false},{"pmid":"37076499","id":"PMC_37076499","title":"Upregulation of KLK8 contributes to CUMS-induced hippocampal neuronal apoptosis by cleaving NCAM1.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37076499","citation_count":32,"is_preprint":false},{"pmid":"1856291","id":"PMC_1856291","title":"Expression of neural cell adhesion molecule (NCAM) isoforms in neuroblastoma.","date":"1991","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/1856291","citation_count":32,"is_preprint":false},{"pmid":"8535222","id":"PMC_8535222","title":"Expression of N-CAM (CD56) on acute leukemia cells: relationship with disease characteristics and outcome.","date":"1995","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/8535222","citation_count":32,"is_preprint":false},{"pmid":"11820619","id":"PMC_11820619","title":"Significance of cell adhesion molecules, CD56/NCAM in particular, in human tumor growth and spreading.","date":"2001","source":"Folia histochemica et cytobiologica","url":"https://pubmed.ncbi.nlm.nih.gov/11820619","citation_count":31,"is_preprint":false},{"pmid":"15883837","id":"PMC_15883837","title":"SNPs in the neural cell adhesion molecule 1 gene (NCAM1) may be associated with human neural tube defects.","date":"2005","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15883837","citation_count":31,"is_preprint":false},{"pmid":"7522719","id":"PMC_7522719","title":"CD56 (NCAM)-positive malignant lymphoma.","date":"1994","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/7522719","citation_count":30,"is_preprint":false},{"pmid":"35492247","id":"PMC_35492247","title":"Autoantibodies against NCAM1 from patients with schizophrenia cause schizophrenia-related behavior and changes in synapses in mice.","date":"2022","source":"Cell reports. Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35492247","citation_count":30,"is_preprint":false},{"pmid":"9154219","id":"PMC_9154219","title":"NCAM and schizophrenia: genetic studies.","date":"1997","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/9154219","citation_count":30,"is_preprint":false},{"pmid":"33231295","id":"PMC_33231295","title":"Deep phenotypical characterization of human CD3+ CD56+ T cells by mass cytometry.","date":"2020","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33231295","citation_count":30,"is_preprint":false},{"pmid":"28870505","id":"PMC_28870505","title":"TGF-β1 affects cell-cell adhesion in the heart in an NCAM1-dependent mechanism.","date":"2017","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/28870505","citation_count":29,"is_preprint":false},{"pmid":"11174380","id":"PMC_11174380","title":"CD2- CD4+ CD56+ hematodermic/hematolymphoid malignancy.","date":"2001","source":"Journal of the American Academy of Dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/11174380","citation_count":29,"is_preprint":false},{"pmid":"24651862","id":"PMC_24651862","title":"Characterisation of genetic variation in ST8SIA2 and its interaction region in NCAM1 in patients with bipolar disorder.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24651862","citation_count":28,"is_preprint":false},{"pmid":"18231917","id":"PMC_18231917","title":"Clinicopathological correlates of plasma cell CD56 (NCAM) expression in multiple myeloma.","date":"2008","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/18231917","citation_count":27,"is_preprint":false},{"pmid":"2292721","id":"PMC_2292721","title":"NCAM in the organ of Corti of the developing mouse.","date":"1990","source":"Journal of neurocytology","url":"https://pubmed.ncbi.nlm.nih.gov/2292721","citation_count":26,"is_preprint":false},{"pmid":"27879349","id":"PMC_27879349","title":"NCAM1 Polysialylation: The Prion Protein's Elusive Reason for Being?","date":"2016","source":"ASN neuro","url":"https://pubmed.ncbi.nlm.nih.gov/27879349","citation_count":25,"is_preprint":false},{"pmid":"16519701","id":"PMC_16519701","title":"Correlation between expression of CD56/NCAM and severe leukostasis in hyperleukocytic acute myelomonocytic leukaemia.","date":"2006","source":"European journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/16519701","citation_count":25,"is_preprint":false},{"pmid":"19788570","id":"PMC_19788570","title":"NCAM expression induces neurogenesis in vivo.","date":"2009","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19788570","citation_count":24,"is_preprint":false},{"pmid":"27095082","id":"PMC_27095082","title":"Pharmacological approach for targeting dysfunctional brain plasticity: Focus on neural cell adhesion molecule (NCAM).","date":"2016","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/27095082","citation_count":24,"is_preprint":false},{"pmid":"8488756","id":"PMC_8488756","title":"Expression of NCAM mRNA and polypeptides in aging rat brain.","date":"1993","source":"International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/8488756","citation_count":24,"is_preprint":false},{"pmid":"15096371","id":"PMC_15096371","title":"CD56+ lymphoma with skin involvement: clinicopathologic features and classification.","date":"2004","source":"Archives of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/15096371","citation_count":24,"is_preprint":false},{"pmid":"25273375","id":"PMC_25273375","title":"NCAM1-TTC12-ANKK1-DRD2 variants and smoking motives as intermediate phenotypes for nicotine dependence.","date":"2014","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25273375","citation_count":23,"is_preprint":false},{"pmid":"35775327","id":"PMC_35775327","title":"Human NK cells responses are enhanced by CD56 engagement.","date":"2022","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35775327","citation_count":23,"is_preprint":false},{"pmid":"21323521","id":"PMC_21323521","title":"Immunophenotypic characteristics and clinical relevance of CD56+ and CD56- extranodal nasal-type natural killer/T-cell lymphoma.","date":"2011","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/21323521","citation_count":23,"is_preprint":false},{"pmid":"23240056","id":"PMC_23240056","title":"Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23240056","citation_count":23,"is_preprint":false},{"pmid":"28076782","id":"PMC_28076782","title":"GFRα1 Regulates Purkinje Cell Migration by Counteracting NCAM Function.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28076782","citation_count":22,"is_preprint":false},{"pmid":"31816056","id":"PMC_31816056","title":"NCAM regulates temporal specification of neural progenitor cells via profilin2 during corticogenesis.","date":"2020","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31816056","citation_count":22,"is_preprint":false},{"pmid":"31862845","id":"PMC_31862845","title":"The Drosophila NCAM homolog Fas2 signals independently of adhesion.","date":"2020","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31862845","citation_count":22,"is_preprint":false},{"pmid":"28414590","id":"PMC_28414590","title":"Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease.","date":"2017","source":"Immunological investigations","url":"https://pubmed.ncbi.nlm.nih.gov/28414590","citation_count":21,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46382,"output_tokens":7246,"usd":0.123918,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16592,"output_tokens":7467,"usd":0.134818,"stage2_stop_reason":"end_turn"},"total_usd":0.258736,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1988,\n      \"finding\": \"NCAM polysialic acid (PSA) content regulates cell-cell adhesion by steric hindrance: high PSA content increases intermembrane repulsion and inhibits membrane apposition, while low PSA content promotes adhesion and triggers contact-dependent intercellular events.\",\n      \"method\": \"Cell adhesion assays, biochemical analysis of PSA content\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — foundational finding replicated across many subsequent studies with multiple orthogonal methods\",\n      \"pmids\": [\"3281256\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"PSA-NCAM is required for activity-induced synaptic plasticity (LTP and LTD) in hippocampal slices; enzymatic removal of PSA with endoneuraminidase-N completely prevented LTP and LTD induction, and recovery of PSA immunoreactivity correlated with full recovery of plasticity. NCAM-deficient mice also showed decaying LTP.\",\n      \"method\": \"Enzymatic PSA removal (endoneuraminidase-N), hippocampal organotypic slice cultures, electrophysiology in NCAM knockout mice\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct enzymatic intervention plus genetic knockout, replicated with multiple approaches in same study\",\n      \"pmids\": [\"8816705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"NCAM is essential for axonal fasciculation and pathfinding of hippocampal mossy fibers in vivo; NCAM-null mice show strongly disrupted fasciculation, pathfinding, and altered distribution of mossy fiber terminals, with a more severe phenotype in adults than young animals.\",\n      \"method\": \"NCAM knockout mice (gene targeting), histological and immunofluorescence analysis of hippocampal mossy fiber tract\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockout with defined anatomical phenotype, replicated across developmental stages\",\n      \"pmids\": [\"9073395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"NCAM140 clustering activates a signaling cascade: p125FAK → p59Fyn → Ras → MEK → ERK1/2 (MAPK) activation, leading to CREB phosphorylation at Ser133. This pathway is required for NCAM-stimulated neurite outgrowth in cerebellar neurons.\",\n      \"method\": \"NCAM clustering assay, phosphorylation assays (Western blot), kinase inhibitors, dominant-negative constructs, neurite outgrowth assay\",\n      \"journal\": \"Journal of neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple signaling intermediates identified with inhibitor experiments and phosphorylation assays in a single study\",\n      \"pmids\": [\"10084688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Crystal structure (1.85 Å) of the two N-terminal extracellular Ig domains of NCAM reveals a cross-shaped antiparallel dimer as the structural basis for homophilic trans-cellular recognition and adhesion.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"Nature structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structure providing direct structural basis for homophilic binding\",\n      \"pmids\": [\"10802736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Lipid raft association of NCAM140 is required for activation of the non-receptor tyrosine kinase pathway (FAK and ERK1/2) and neurite outgrowth. Mutation of NCAM140 palmitoylation sites or lipid raft disruption abolishes tyrosine kinase activation and neurite outgrowth. Additionally, FGF receptor co-signaling is also required, as a specific FGFR inhibitor completely blocks NCAM-triggered neurite outgrowth.\",\n      \"method\": \"Transfection of NCAM-deficient hippocampal neurons, palmitoylation site mutagenesis, lipid raft disruption (methyl-β-cyclodextrin), FGFR-specific inhibitor, kinase phosphorylation assays, neurite outgrowth assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — mutagenesis, pharmacological disruption, and functional readout in same study with multiple orthogonal methods\",\n      \"pmids\": [\"11980923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"NCAM140 reduces cell motility by interfering with fibronectin substratum attachment and through its cytoplasmic domain via interaction with p59Fyn. The extracellular domain of NCAM also acts as a paracrine inhibitor of NCAM-negative cell locomotion via heterophilic interaction with heparan sulfate proteoglycans (through the two N-terminal Ig modules).\",\n      \"method\": \"NCAM transfection, motility assays, fibronectin adhesion assay, domain deletion constructs, heparin-binding assays\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple domain constructs and functional assays in single study, single lab\",\n      \"pmids\": [\"11839780\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"NCAM120, NCAM140, and NCAM180 form detergent-insoluble complexes with βI spectrin in hippocampal neurons. βI spectrin binds directly to the intracellular domain of NCAM180 and to NCAM140. PKCβ2 forms complexes with NCAM140/NCAM180 via spectrin as a bridge. NCAM activation promotes redistribution of the NCAM-spectrin-PKCβ2 complex to lipid rafts, and disruption of spectrin binding (by dominant-negative βI spectrin fragments) impairs neurite outgrowth.\",\n      \"method\": \"Co-immunoprecipitation, subcellular fractionation (Triton X-100 insoluble complexes/lipid rafts), dominant-negative constructs, methyl-β-cyclodextrin treatment, neurite outgrowth assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, dominant-negative functional assay, lipid raft disruption, multiple orthogonal methods\",\n      \"pmids\": [\"12743109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NCAM140 directly interacts with the intracellular domain of RPTPα (receptor-like protein tyrosine phosphatase alpha) in a Ca2+-independent manner. This NCAM-RPTPα complex is bridged by spectrin and redistributes to lipid rafts upon NCAM activation. RPTPα is required to link NCAM to p59Fyn kinase activation; in RPTPα-deficient neurons, NCAM-Fyn association and Fyn activation are abolished, and NCAM-dependent neurite outgrowth is blocked.\",\n      \"method\": \"Co-immunoprecipitation, RPTPα-deficient mouse neurons, dominant-negative RPTPα mutants, kinase activation assays, neurite outgrowth assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct interaction, knockout confirmation, dominant-negative validation, and functional readout in one study\",\n      \"pmids\": [\"15623578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NCAM polysialylation directly increases intermembrane repulsion (measured by molecular force measurements), sufficient to overwhelm homophilic NCAM adhesion and cadherin-mediated adhesion. The steric repulsion is ionic strength-dependent, and PSA-dependent attenuation of cadherin adhesion increases with PSA-NCAM:cadherin ratio.\",\n      \"method\": \"Molecular force measurements (surface force apparatus) using membrane-bound NCAM with and without PSA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — quantitative biophysical reconstitution measuring direct repulsive force, rigorous controls for ionic strength and PSA density\",\n      \"pmids\": [\"15504723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GAP-43 phosphorylation (by PKC and CKII) potentiates NCAM-induced neurite outgrowth. In the presence of GAP-43, NCAM-180/spectrin/GAP-43 functional association is required for neurite outgrowth; in the absence of GAP-43, the NCAM-140/Fyn signaling pathway is predominant. GAP-43 thus acts as a molecular switch between NCAM-180 and NCAM-140 signaling.\",\n      \"method\": \"Overexpression and phosphorylation mutants in PC12E2 cells and hippocampal neurons, neurite outgrowth assay, co-immunoprecipitation\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple isoform constructs, phosphorylation mutants, and functional assays in single lab\",\n      \"pmids\": [\"17212696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NCAM clustering induces Ca2+ influx via T- and L-type voltage-dependent Ca2+ channels associated with NCAM, activating CaMKIIα which phosphorylates RPTPα at Ser180 and Ser204, enhancing RPTPα phosphatase activity. Overexpression of RPTPα with mutated Ser180/Ser204 inhibits NCAM-induced neurite outgrowth.\",\n      \"method\": \"Co-immunoprecipitation, Ca2+ channel blockers, CaMKIIα inhibitors, phosphorylation assays, RPTPα serine mutagenesis, neurite outgrowth assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct binding, mutagenesis, kinase cascade dissection, and functional readout with multiple orthogonal methods\",\n      \"pmids\": [\"18809727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Neuronal membrane depolarization triggers skipping of NCAM exon 18 independently of the CaMKIV pathway, through a kinetic coupling mechanism: H3K9 hyper-acetylation is induced in an intragenic region surrounding the alternative exon (without promoter acetylation), associated with chromatin relaxation and H3K36 tri-methylation, which accelerates RNA Pol II elongation and promotes exon skipping.\",\n      \"method\": \"Depolarization of neuronal cells, slow RNAP II mutant, chromatin immunoprecipitation (H3K9ac, H3K36me3), HDAC inhibitor trichostatin A, RT-PCR for alternative splicing\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple chromatin assays, genetic RNAP II mutant, pharmacological validation with reversion experiment\",\n      \"pmids\": [\"19251664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Ectopic expression of NCAM140 in radial glia and type C cells in vivo induces increased cell proliferation and generation of additional neuronal type A cells in the rostral migratory stream. This neurogenic effect requires only the fibronectin type III repeats and Ig-domain 5 of NCAM and is independent of polysialylation (as transgenic NCAM in these cells is not polysialylated), implicating heterophilic NCAM interactions.\",\n      \"method\": \"In vivo retroviral/lentiviral overexpression in postnatal mouse brain, domain deletion mutants, PSA immunostaining, cell counting (BrdU/doublecortin)\",\n      \"journal\": \"The European journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain mapping with deletion mutants in vivo, single lab\",\n      \"pmids\": [\"19788570\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NCAM directly interacts with p21-activated kinase 1 (Pak1) in growth cones (identified by yeast two-hybrid and confirmed in neurons). NCAM activation enhances Pak1 autophosphorylation/activity, promotes Pak1 membrane association, and activates downstream LIMK1 and cofilin phosphorylation, increasing filamentous actin and filopodium mobility. Pak1 is required for NCAM-dependent neurite outgrowth.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation in growth cones, NCAM-deficient mouse brains, dominant-negative and constitutively active Pak1 constructs, actin polymerization assay, neurite outgrowth assay\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — yeast two-hybrid identified interaction confirmed by co-IP in neurons, knockout validation, gain/loss-of-function of downstream effector, multiple orthogonal methods\",\n      \"pmids\": [\"23303955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TGFβ1 induces NCAM1 expression in cardiomyocytes via a p38-dependent pathway. NCAM1 upregulation mediates TGFβ1-induced cell-cell adhesion defects at intercalated discs; selective targeting of NCAM1 rescues the cell adhesion defect caused by TGFβ1 treatment.\",\n      \"method\": \"Cardiac-specific TGFβ1 transgenic mice, electron microscopy, immunostaining, p38 inhibition, siRNA knockdown of NCAM1, rescue assay in cardiomyocytes\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway dissection with p38 inhibitor and NCAM1 knockdown rescue, single lab\",\n      \"pmids\": [\"28870505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GFRα1 counteracts NCAM function during Purkinje cell migration: GFRα1 directly interacts with NCAM in embryonic Purkinje cells, and genetic reduction of NCAM enhances wild-type Purkinje cell migration and restores migration in Gfra1 mutants. GFRα1 can act both in cis and trans to limit NCAM-mediated restriction of Purkinje cell migration.\",\n      \"method\": \"Gfra1 and Ncam knockout/heterozygous mice, co-immunoprecipitation of GFRα1 and NCAM, in vitro migration assays with cis/trans GFRα1 constructs\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis (double mutant rescue), direct protein interaction, and in vitro mechanistic validation\",\n      \"pmids\": [\"28076782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Peripheral nerve injury increases NCAM1 turnover in the anterior cingulate cortex (ACC), and NCAM1 mediates spine reorganization in ACC neurons contributing to behavioral sensitization (neuropathic pain). This mechanism parallels NMDA-receptor- and protein-synthesis-dependent LTP maintenance.\",\n      \"method\": \"Peripheral nerve injury model, protein turnover assays, spine morphology analysis, behavioral sensitization tests, NCAM1 manipulation in ACC\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with defined spine reorganization and behavioral phenotype, single lab\",\n      \"pmids\": [\"29346771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NCAM1 promotes leukemogenesis and confers drug resistance in AML by constitutively activating the MAPK signaling pathway. NCAM1 perturbation induces cell death or differentiation and sensitizes leukemic blasts to genotoxic agents in vitro and in vivo. In a murine AML model, Ncam1 deletion prolonged disease latency and reduced leukemia-initiating cells. Pharmacological MEK1/2 inhibition specifically inhibits NCAM1+ AML cell proliferation.\",\n      \"method\": \"CRISPR/Cas9 knockout and shRNA knockdown, phosphoproteomics, transcriptomics, serial transplantation in murine AML model, MEK1/2 inhibitor treatment, in vitro and in vivo drug sensitivity assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — complementary genetic strategies (CRISPR + shRNA), phosphoproteomics pathway mapping, in vivo serial transplantation, replicated with pharmacological inhibition\",\n      \"pmids\": [\"30814062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NCAM1 functions as an entry receptor for Zika virus (ZIKV): chemical proteomics with photo-crosslinking identified NCAM1 as a ZIKV-interacting protein in living cells, and overexpression, knockout, and inhibition of NCAM1 in Vero cells and human glioblastoma cells validated its role in ZIKV internalization.\",\n      \"method\": \"Time-resolved chemical proteomics (photocrosslinking + biotin enrichment + mass spectrometry), NCAM1 overexpression, CRISPR knockout, inhibition in cell lines\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — chemical crosslinking proteomics for receptor identification, validated by three orthogonal genetic approaches (OE, KO, inhibition)\",\n      \"pmids\": [\"32753727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CD56 (NCAM1) regulates NK cell cytotoxicity through Pyk2: CD56 deletion in NK92 cells impairs immunological synapse formation, lytic granule polarization and exocytosis, and reduces Pyk2 phosphorylation at Tyr402. Reintroduction of CD56 rescues cytotoxicity, granule exocytosis, and Pyk2 phosphorylation.\",\n      \"method\": \"CRISPR/Cas9 CD56 knockout in NK92 cells, rescue by CD56 reintroduction, lytic granule exocytosis assay, immunological synapse imaging, Pyk2 phosphorylation assay\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean CRISPR KO with full rescue experiment, defined biochemical (Pyk2 phosphorylation) and functional (exocytosis, cytotoxicity) readouts\",\n      \"pmids\": [\"32510326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NCAM regulates temporal specification of neural progenitor cells (NPCs) during corticogenesis by interacting with profilin2 to enhance actin polymerization. NPC-specific NCAM deletion reduces NPC proliferation, delays cortical neuron production, and advances gliogenesis. Mutations in the profilin2-binding site of NCAM abolish these regulatory effects.\",\n      \"method\": \"NPC-specific NCAM conditional knockout mice, co-immunoprecipitation of NCAM-profilin2, actin polymerization assay, profilin2-binding site mutagenesis, BrdU/EdU labeling, cortical layer marker immunostaining\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — conditional knockout, direct binding validated by co-IP, site-directed mutagenesis, and in vivo cellular phenotype\",\n      \"pmids\": [\"31816056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Anti-NCAM1 autoantibodies from schizophrenia patients disrupt NCAM1-NCAM1 homophilic interactions, NCAM1-GDNF interactions, and the NCAM1-Fyn interaction; they inhibit FAK, MEK1, and ERK1 phosphorylation when introduced into mouse cerebrospinal fluid, reduce spine and synapse density in frontal cortex, and induce schizophrenia-related behavior (deficient pre-pulse inhibition and cognitive impairment).\",\n      \"method\": \"Cell-based assay and ELISA for autoantibody detection; purified patient antibody injection into mouse CSF; spine/synapse counting by immunofluorescence; behavioral tests (PPI, cognitive tasks); phosphorylation assays\",\n      \"journal\": \"Cell reports. Medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — patient-derived antibody with in vivo functional consequence and downstream signaling measured, but single lab and partially dependent on patient material\",\n      \"pmids\": [\"35492247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"KLK8 (kallikrein-related peptidase 8) proteolytically cleaves the extracellular domain of NCAM1. KLK8-mediated NCAM1 cleavage contributes to hippocampal neuronal apoptosis in CUMS-induced depression. Overexpression of NCAM1 or NCAM1 mimetic peptide rescues neurons from KLK8-induced apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, in vitro cleavage assay, adenovirus-mediated KLK8 overexpression in hippocampal neurons, KLK8 transgenic and knockout mice, NCAM1 overexpression rescue, CUMS mouse/rat models, immunofluorescence\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct cleavage assay and rescue experiments, single lab with multiple genetic and cellular approaches\",\n      \"pmids\": [\"37076499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Polysialylation of NCAM is catalyzed by a single enzyme (PST-1/ST8SIA4) acting on terminal sialylated N-glycans on NCAM; reconstitution in vitro using incompletely glycosylated NCAM variants and soluble recombinant PST-1 demonstrated that a single enzyme is sufficient and that terminal sialylation of the N-glycan core (via either α2,3 or α2,6 linkage to galactose) generates the PSA acceptor site.\",\n      \"method\": \"In vitro reconstitution with recombinant PST-1, incompletely glycosylated NCAM variants, glycosyltransferase assay\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro enzymatic reconstitution with defined substrates demonstrating single-enzyme catalysis\",\n      \"pmids\": [\"8805371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"LEF-1 and Alx4 can bind simultaneously to adjacent sites on the NCAM promoter (through Alx4's proline-rich N-terminal domain interacting with LEF-1's HMG-box), and this binding alters NCAM promoter activity. Alx4 expression in primary mammary stromal cells decreases endogenous NCAM protein levels.\",\n      \"method\": \"Protein interaction assays (co-immunoprecipitation/GST pulldown), EMSA on NCAM promoter, promoter reporter assay, endogenous NCAM protein measurement in Alx4-transfected stromal cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding mapped to specific domains, promoter binding and activity assay, endogenous protein regulation, single lab\",\n      \"pmids\": [\"11696550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ST8SiaIV (PST) is the major regulator of NCAM polysialylation in vivo based on differential mRNA expression correlating with PSA levels; ST8SiaII and ST8SiaIV both polysialylate N-glycosylation sites 5 and 6 of NCAM but produce polySia chains of different lengths, with synergistic action required for synthesis of long polySia chains at site 5.\",\n      \"method\": \"ST8SiaII and ST8SiaIV knockout mice; isolation and tryptic digestion of polySia-NCAM from mouse brains; glycan structural analysis of polysialylated glycopeptides\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vivo structural analysis with single and double enzyme knockout mice plus glycan fine-structure characterization\",\n      \"pmids\": [\"17986444\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NCAM1 (CD56) is a multifunctional Ig-superfamily cell adhesion molecule that mediates homophilic adhesion via an antiparallel cis-dimer/trans-zipper mechanism (crystal structure defined), and whose adhesive properties are negatively regulated by polysialic acid (PSA) modification—catalyzed by ST8SIA2/ST8SIA4—through steric intermembrane repulsion; upon homophilic or heterophilic engagement, the NCAM140 isoform signals via lipid-raft-dependent activation of a FAK/Fyn/Ras/MAPK/CREB cascade—requiring RPTPα as a phosphatase bridge to Fyn, spectrin as a scaffold for PKCβ2 and GAP-43 recruitment, CaMKIIα-mediated RPTPα activation via NCAM-associated Ca2+ channels, and Pak1-mediated actin polymerization via LIMK1/cofilin—to drive neurite outgrowth, while in neural progenitors NCAM regulates actin polymerization via profilin2 to control cortical neuron vs. glia fate; in NK cells NCAM1/CD56 promotes cytotoxic lytic granule exocytosis through Pyk2 phosphorylation; in AML cells NCAM1 maintains leukemic stem cells via constitutive MAPK activation; and the extracellular domain can be proteolytically cleaved by KLK8 or act as a Zika virus entry receptor.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NCAM1 (CD56) is an immunoglobulin-superfamily cell adhesion molecule that mediates homophilic trans-cellular recognition through an antiparallel, cross-shaped dimer formed by its N-terminal Ig domains [#4], and that organizes axonal fasciculation, synaptic plasticity, and neuronal migration in the nervous system [#1, #2]. Its adhesive activity is tuned post-translationally by polysialic acid (PSA): polysialylation, catalyzed by the ST8SIA enzymes (PST-1/ST8SIA4 and ST8SIA2) on terminal sialylated N-glycans [#24, #26], generates steric intermembrane repulsion that overrides homophilic NCAM and cadherin adhesion in a force- and ionic-strength-dependent manner [#9, #0], and PSA is required for hippocampal LTP and LTD [#1]. Upon clustering, the NCAM140 isoform signals from lipid rafts through a non-receptor tyrosine kinase cascade—FAK→Fyn→Ras→MEK→ERK1/2→CREB—to drive neurite outgrowth [#3, #5], a cascade assembled by a βI-spectrin scaffold that bridges PKCβ2 and GAP-43 [#7, #10] and by RPTPα, which links NCAM to Fyn and is itself activated by CaMKIIα-mediated phosphorylation downstream of NCAM-associated Ca2+ channels [#8, #11]. NCAM also remodels the actin cytoskeleton, activating Pak1→LIMK1→cofilin to promote filopodial actin polymerization [#14] and engaging profilin2 to control neural progenitor proliferation and the neuron-versus-glia fate decision during corticogenesis [#21]. Beyond the nervous system, NCAM1 sustains acute myeloid leukemia stem cells through constitutive MAPK activation, rendering NCAM1+ blasts sensitive to MEK1/2 inhibition [#18], promotes NK-cell cytotoxicity by supporting immunological synapse formation and lytic granule exocytosis via Pyk2 phosphorylation [#20], and serves as a Zika virus entry receptor [#19]. Its ectodomain is proteolytically cleaved by KLK8, linking NCAM1 loss to hippocampal neuronal apoptosis [#23], and anti-NCAM1 autoantibodies that disrupt its homophilic and Fyn interactions produce schizophrenia-related deficits [#22].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Established that NCAM adhesive function is not constitutive but is set by a post-translational modification, defining PSA as a regulatory switch on cell-cell apposition.\",\n      \"evidence\": \"Cell adhesion assays correlating PSA content with intermembrane repulsion\",\n      \"pmids\": [\"3281256\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not quantify the physical repulsive force\", \"Enzymes generating PSA not yet identified\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Resolved how PSA-NCAM is biosynthesized by showing a single recombinant enzyme suffices to polysialylate terminally sialylated N-glycans, defining the acceptor requirement.\",\n      \"evidence\": \"In vitro reconstitution with recombinant PST-1/ST8SIA4 and incompletely glycosylated NCAM variants\",\n      \"pmids\": [\"8805371\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo contribution of multiple sialyltransferases not addressed\", \"Chain-length determinants unresolved\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Connected PSA-NCAM to functional plasticity, showing PSA is required for activity-dependent LTP/LTD and that NCAM loss degrades plasticity.\",\n      \"evidence\": \"Enzymatic PSA removal and electrophysiology in NCAM knockout hippocampal slices\",\n      \"pmids\": [\"8816705\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling linking PSA to plasticity not defined\", \"Synaptic versus extrasynaptic site of action unresolved\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrated an in vivo developmental requirement for NCAM in axonal fasciculation and pathfinding, anchoring its adhesive role in circuit assembly.\",\n      \"evidence\": \"Histological analysis of mossy fiber tracts in NCAM knockout mice\",\n      \"pmids\": [\"9073395\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not separate homophilic from heterophilic contributions\", \"Molecular signaling mechanism not addressed\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Provided the structural basis for homophilic recognition, revealing an antiparallel cross-shaped Ig-domain dimer as the trans-adhesion unit.\",\n      \"evidence\": \"1.85 Å X-ray crystallography of the two N-terminal Ig domains\",\n      \"pmids\": [\"10802736\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length ectodomain trans-zipper geometry not captured\", \"Effect of PSA on the binding interface not modeled\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defined the intracellular signaling consequence of NCAM engagement as a FAK→Fyn→Ras→MAPK→CREB cascade required for neurite outgrowth, converting adhesion into a transcriptional response.\",\n      \"evidence\": \"NCAM140 clustering, kinase inhibitors, dominant-negatives, and neurite outgrowth assays in cerebellar neurons\",\n      \"pmids\": [\"10084688\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How clustering reaches FAK/Fyn not yet mechanistically defined\", \"Membrane platform for signaling unidentified\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Localized NCAM140 signaling to lipid rafts via palmitoylation and revealed obligatory FGFR co-signaling, explaining where and with which partner the kinase cascade is triggered.\",\n      \"evidence\": \"Palmitoylation mutagenesis, raft disruption, FGFR inhibition, and neurite outgrowth in NCAM-deficient neurons\",\n      \"pmids\": [\"11980923\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular link between rafts and FAK/Fyn activation not yet specified\", \"Stoichiometry of NCAM-FGFR engagement unresolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showed NCAM140 also restrains cell motility through Fyn and through heterophilic engagement of heparan sulfate proteoglycans, broadening its role beyond promotion of outgrowth.\",\n      \"evidence\": \"Motility/adhesion assays and domain-deletion constructs in transfected cells\",\n      \"pmids\": [\"11839780\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab functional assays\", \"In vivo relevance of the paracrine motility inhibition not tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identified βI spectrin as the scaffold that physically bridges NCAM to PKCβ2 and recruits the complex to rafts, providing the structural organizer of the signaling assembly.\",\n      \"evidence\": \"Reciprocal co-IP, raft fractionation, dominant-negative spectrin, and neurite outgrowth assays\",\n      \"pmids\": [\"12743109\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How spectrin coordinates with the Fyn arm not fully resolved\", \"Isoform-specific scaffolding differences only partly defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Resolved how NCAM activates Fyn by identifying RPTPα as the phosphatase bridge required for Fyn association and activation, filling the gap between clustering and kinase activity.\",\n      \"evidence\": \"Co-IP, RPTPα-deficient neurons, dominant-negative RPTPα, and neurite outgrowth assays\",\n      \"pmids\": [\"15623578\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trigger for RPTPα phosphatase activation not yet identified\", \"Cis versus trans engagement requirement unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Quantitatively demonstrated that polysialylation generates a direct repulsive force sufficient to override both NCAM and cadherin adhesion, providing the biophysical mechanism for PSA-dependent de-adhesion.\",\n      \"evidence\": \"Surface force apparatus measurements on membrane-bound NCAM ± PSA\",\n      \"pmids\": [\"15504723\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo membrane-context validation limited\", \"Effect on heterophilic ligands beyond cadherin not measured\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined GAP-43 as a molecular switch directing signaling between the NCAM180/spectrin and NCAM140/Fyn pathways, explaining isoform-specific routing of the outgrowth signal.\",\n      \"evidence\": \"Isoform and phosphorylation-mutant overexpression, co-IP, and neurite outgrowth in PC12E2 cells and neurons\",\n      \"pmids\": [\"17212696\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab data\", \"Physiological context selecting one pathway over the other not defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified the activation trigger for RPTPα as a Ca2+/CaMKIIα circuit, showing NCAM-associated Ca2+ channels phosphorylate RPTPα to enhance its phosphatase activity.\",\n      \"evidence\": \"Ca2+ channel blockers, CaMKIIα inhibitors, RPTPα Ser180/Ser204 mutagenesis, and neurite outgrowth assays\",\n      \"pmids\": [\"18809727\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity and gating of the NCAM-associated channels not fully defined\", \"Spatial coupling of channels to the signaling complex unresolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Connected neuronal depolarization to NCAM isoform choice via a chromatin/elongation kinetic-coupling mechanism, revealing activity-dependent regulation of NCAM exon 18 splicing.\",\n      \"evidence\": \"Depolarization, slow RNAP II mutant, ChIP for H3K9ac/H3K36me3, and HDAC inhibition with RT-PCR\",\n      \"pmids\": [\"19251664\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of the spliced isoform not tested here\", \"Upstream signal linking depolarization to chromatin marks not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed NCAM140 promotes neurogenic proliferation in vivo through heterophilic, PSA-independent interactions, mapping the activity to the FnIII repeats and Ig domain 5.\",\n      \"evidence\": \"In vivo viral overexpression with domain-deletion mutants and BrdU/doublecortin counting\",\n      \"pmids\": [\"19788570\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Heterophilic partner not identified\", \"Single-lab in vivo evidence\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Linked NCAM signaling to direct actin remodeling by identifying Pak1 as a partner driving LIMK1/cofilin-dependent actin polymerization in growth cones.\",\n      \"evidence\": \"Yeast two-hybrid, co-IP in growth cones, NCAM-deficient brains, Pak1 gain/loss constructs, and actin/neurite assays\",\n      \"pmids\": [\"23303955\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Coordination between Pak1 and the FAK/Fyn cascade unresolved\", \"Direct binding interface not mapped\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Extended NCAM cytoskeletal control to cell-fate decisions, showing NCAM-profilin2 interaction tunes actin polymerization to set the timing of cortical neurogenesis versus gliogenesis.\",\n      \"evidence\": \"NPC-specific conditional knockout, NCAM-profilin2 co-IP, binding-site mutagenesis, and cortical layer/lineage analysis\",\n      \"pmids\": [\"31816056\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal upstream of profilin2 engagement not defined\", \"Relationship to PSA regulation in NPCs unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated NCAM acts in functional opposition to GFRα1 during Purkinje cell migration, establishing genetic epistasis between an adhesion molecule and a GDNF co-receptor.\",\n      \"evidence\": \"Gfra1/Ncam mutant epistasis, GFRα1-NCAM co-IP, and cis/trans migration assays\",\n      \"pmids\": [\"28076782\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream effectors of the GFRα1-NCAM interaction not defined\", \"Whether intracellular signaling is engaged unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Implicated NCAM1 in cardiac pathology, showing TGFβ1 induces NCAM1 via p38 to cause intercalated-disc adhesion defects.\",\n      \"evidence\": \"Cardiac TGFβ1 transgenic mice, p38 inhibition, NCAM1 siRNA knockdown, and rescue in cardiomyocytes\",\n      \"pmids\": [\"28870505\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study\", \"Mechanism by which NCAM1 disrupts disc adhesion not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extended NCAM1's plasticity role to disease by showing injury-induced NCAM1 turnover mediates cortical spine reorganization and behavioral sensitization in neuropathic pain.\",\n      \"evidence\": \"Nerve injury model, protein turnover and spine morphology analysis, and ACC NCAM1 manipulation with behavioral tests\",\n      \"pmids\": [\"29346771\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular signaling driving spine changes not defined\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established a non-neural pathogenic role, showing NCAM1 maintains AML leukemic stem cells through constitutive MAPK activation and confers a MEK-inhibitor vulnerability.\",\n      \"evidence\": \"CRISPR/shRNA depletion, phosphoproteomics, serial transplantation in murine AML, and MEK1/2 inhibition\",\n      \"pmids\": [\"30814062\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How NCAM1 constitutively engages MAPK in leukemia not defined\", \"Ligand/clustering requirement in AML unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined a mechanism for NCAM1 in immune cytotoxicity, showing CD56 supports immunological synapse formation and lytic granule exocytosis through Pyk2 phosphorylation.\",\n      \"evidence\": \"CRISPR knockout with rescue in NK92 cells, synapse imaging, exocytosis assays, and Pyk2 phosphorylation\",\n      \"pmids\": [\"32510326\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream link from CD56 engagement to Pyk2 not defined\", \"Homophilic versus heterophilic trigger in NK cells unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified NCAM1 as a Zika virus entry receptor, assigning it a role in viral internalization in neural and other cell types.\",\n      \"evidence\": \"Photo-crosslinking chemical proteomics with NCAM1 overexpression, knockout, and inhibition in cell lines\",\n      \"pmids\": [\"32753727\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Viral domain engaging NCAM1 not mapped\", \"Internalization machinery downstream of NCAM1 binding unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Connected NCAM1 to schizophrenia, showing patient autoantibodies disrupt homophilic, GDNF, and Fyn interactions, suppress FAK/MEK/ERK signaling, and reduce synapse density to produce disease-related behavior.\",\n      \"evidence\": \"Patient antibody detection and CSF injection in mice with phosphorylation, spine/synapse, and behavioral readouts\",\n      \"pmids\": [\"35492247\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study partly dependent on patient material\", \"Causal role of autoantibodies in patients not established\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified KLK8 as a protease that cleaves the NCAM1 ectodomain and linked this cleavage to hippocampal neuronal apoptosis in a depression model.\",\n      \"evidence\": \"In vitro cleavage assay, KLK8 overexpression, transgenic/knockout mice, and NCAM1 rescue in CUMS models\",\n      \"pmids\": [\"37076499\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cleavage site and fate of cleaved fragments not defined\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Resolved the in vivo division of labor between polysialyltransferases, showing ST8SiaIV is the major regulator and that ST8SiaII/IV act synergistically to build long polySia chains at specific N-glycan sites.\",\n      \"evidence\": \"Single and double sialyltransferase knockout mice with glycan fine-structure analysis of brain polySia-NCAM\",\n      \"pmids\": [\"17986444\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Regulation of enzyme expression/activity not addressed\", \"Functional consequence of differential chain length unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identified transcriptional control of NCAM expression through cooperative LEF-1/Alx4 binding at the NCAM promoter, with Alx4 repressing endogenous NCAM in stromal cells.\",\n      \"evidence\": \"Co-IP/GST pulldown, EMSA, promoter reporter assays, and endogenous protein measurement\",\n      \"pmids\": [\"11696550\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Tissue contexts using this regulation not broadly defined\", \"Single-lab study\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the diverse NCAM-engaging signals (homophilic, heterophilic, viral, autoantibody, constitutive in leukemia) are differentially routed into the shared FAK/Fyn/RPTPα/MAPK and actin machinery to produce context-specific outcomes remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Mechanism of constitutive MAPK engagement in AML undefined\", \"Heterophilic partners for neurogenic and migration roles not all identified\", \"How PSA status integrates with intracellular signaling not mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 4, 9]},\n      {\"term_id\": \"GO:0001618\", \"supporting_discovery_ids\": [19]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [14, 21]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [3, 5, 8]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [7, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [4, 5, 7]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [14, 21]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 5, 8, 18]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 13, 21]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [1, 14]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [20]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [18, 19, 22, 23]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [0, 4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"FYN\", \"PTPRA\", \"SPTB\", \"PAK1\", \"PFN2\", \"GFRA1\", \"KLK8\", \"GAP43\"],\n    \"other_free_text\": []\n  }\n}\n```","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}